ArticleScientific reports2026
Innovative fusion models: elevating preoperative gross ETE prediction in thyroid cancer patients.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The intratumoral and peritumoral architectural heterogeneities of papillary thyroid carcinoma (PTC) are important in preoperative prediction of gross extrathyroidal extension (Gross ETE). This study systematically evaluated and compared the predictive efficacies of deep learning, radiomics, and their combined approach (Deep Learning-Radiomics, DLR) in predicting Gross ETE in PTC patients using ultrasound imaging. This retrospective study from three hospitals, between 01/01/2018, and 12/31/2022, included 4,542 PTC patients, divided into training (n = 3,179) and testing (n = 1,363) sets in a 7:3 ratio. Preoperative ultrasound images and clinical data were collected to develop radiomics and deep learning models based on different tumor expansion regions (5/10/15/20 pixels). A nomogram prediction model was developed by integrating multi-regional radiomics features and key clinical parameters. Model performance was assessed using metrics such as the area under the curve (AUC), sensitivity, and specificity. Feature importance was evaluated using SHapley Additive exPlanations (SHAP) analysis, and model interpretability was analyzed with Gradient-weighted Class Activation Mapping (Grad-CAM). In the test cohort, the radiomics model with 15 pixel expansion (AUC: 0.796) and the ResNet101 deep learning model (AUC: 0.832) showed optimal performance. The DLR model incorporating 15 pixel peritumoral features (DLRexpand15) combined with clinical parameters achieved superior predictive performance (AUC: 0.849, accuracy: 0.857, and specificity: 0.888). SHAP analysis identified deep learning features as the primary predictors in the fusion model, while Grad-CAM visualization confirmed spatial concordances between model-activated regions and histopathological invasion patterns. The DLRexpand15-based nomogram integrating clinical indicators provided an effective tool for preoperative prediction of Gross ETE in PTC patients. Strategic incorporation of peritumoral information significantly enhanced the predictive capacity of both radiomics and deep learning models. This multimodal approach provided clinically useful insights for surgical planning and risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.